C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 241/08 (2006.01) A61K 31/495 (2006.01) A61P 15/10 (2006.01) C07D 241/06 (2006.01) C07D 401/06 (2006.01) C07D 401/12 (2006.01) C07D 401/14 (2006.01) C07D 403/10 (2006.01) C07D 403/12 (2006.01) C07D 403/14 (2006.01) C07D 413/14 (2006.01)
Patent
CA 2506843
The present invention relates to novel compounds of the general formula (I) as well as any optical or geometric isomer or tautomer form thereof, or a pharmaceutically acceptable salt thereof, as agonists of melanocortin receptors, such as agonists of the MC4 receptor. The compounds may for instance be used in the treatment of obesity.
La présente invention concerne de nouveaux composés de la formule générale (I) ainsi que tout isomère optique ou géométrique ou toute forme tautomère de ce dernier, ou leur sel pharmaceutiquement acceptable. L'invention concerne également leur utilisation comme agonistes des récepteurs mélanocortine, notamment comme agonistes du récepteur MC4. On peut utiliser ces composés, par exemple, dans le traitement de l'obésité.
Ankersen Michael
Arndt Kirsten
Conde-Frieboes Kilian Waldemar
Krist Bernd
Lustenberger Philipp
Boehringer Ingelheim International Gmbh
Novo-Nordisk A/s
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
2,5-diketopiperazines for the treatment of obesity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2,5-diketopiperazines for the treatment of obesity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2,5-diketopiperazines for the treatment of obesity will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2057315